Rosiglitazone HCl

Cat. No. M5940

All AbMole products are for research use only, cannot be used for human consumption.

Synonym:

BRL-49653 HCl

Size	Price	Availability	Quantity
50mg	USD 55	In stock
100mg	USD 95	In stock

Free Delivery on orders over USD 500 Bulk Inquiry?

Rosiglitazone HCl is a hypoglycemic compound that stimulates insulin secretion by binding to PPAR receptors in fat cells.

FASEB J. 2017 Oct;31(10):4396-4406.

Protein kinase Cβ activates fat mass and obesity-associated protein by influencing its ubiquitin/proteasome degradation.
Rosiglitazone HCl purchased from AbMole

	Source	The FASEB Journal (2017). Figure 1. Rosiglitazone (Abmole Bioscience, Shanghai, China)
	Method	3T3-L1 cell differentiation
	Cell Lines	3T3-L1 cell
	Concentrations	2mM
	Incubation Time	3 d
	Results	FTO is positively regulated by PKCb. Immunoblot analyses were performed with the indicated antibodies. The quantifications of immunoblots came from 3 repeats of the experiments.

Molecular Weight	393.89
Formula	C18H19N3O3S.HCl
CAS Number	302543-62-0
Solubility (25°C)	79 mg/mL in DMSO
Storage	Powder -20°C 3 years ; 4°C 2 years In solvent -80°C 6 months ; -20°C 1 month

Related PPAR Products
WY 14643 (Pirinixic Acid) WY 14643 (Pirinixic Acid) is a potent and selective, peroxisome proliferator-activated receptor-α (PPARα) agonist.
Rosiglitazone Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50=60 nM, Kd=40 nM). Rosiglitazone is an TRPC5 activator (EC50=30 μM) and TRPM3 inhibitor.
GSK 3787 GSK3787 is an orally available selective peroxisome proliferator-activated receptor δ (PPARδ) antagonist (pIC50 = 6.6).
Rosiglitazone maleate Rosiglitazone maleate (Avandia) is a potent and selective PPARγ ligand that binds to the PPARγ ligand-binding domain with a Kd value of 43 nM.
Ciprofibrate Ciprofibrate is a peroxisome proliferator-activated receptor α (PPARα) agonist.

Catalog